Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Biomolecules
|
March 29, 2023
Alternative mRNA Splicing and Promising Therapies in Cancer
James D Fackenthal
Disease Models & Mechanisms
|
December 3, 2008
Aberrant RNA splicing and its functional consequences in cancer cells
James D Fackenthal, Lucy A Godley
Nature Reviews. Cancer
|
November 24, 2007
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
James D Fackenthal, Olufunmilayo I Olopade
Annals of Epidemiology
|
December 3, 2014
Changes in the pattern of breast cancer burden among African American women: evidence based on 29 states and District of Columbia during 1998 to 2010
Dominique Sighoko, James D Fackenthal, Pierre Hainaut
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2012
Hidden dangers: a cryptic exon disrupts BRCA2 mRNA
James D Fackenthal, Younghee Lee, Olufunmilayo I Olopade
Breast Cancer Research and Treatment
|
July 3, 2010
Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population
Jing Zhang, James D Fackenthal, Dezheng Huo, et al.
American Journal of Human Genetics
|
July 30, 2002
BRCA2 T2722R is a deleterious allele that causes exon skipping
James D Fackenthal, Luca Cartegni, Adrian R Krainer, et al.
Cancer
|
March 19, 2016
Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect
Rodrigo Santa Cruz Guindalini, Andrew Song, James D Fackenthal, et al.
Cancer
|
December 20, 2002
Breast cancer genetics in African Americans
Olufunmilayo I Olopade, James D Fackenthal, Georgia Dunston, et al.
Familial Cancer
|
August 6, 2008
Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry
Bifeng Zhang, James D Fackenthal, Qun Niu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Biomolecules
|
March 29, 2023
Alternative mRNA Splicing and Promising Therapies in Cancer
James D Fackenthal
Disease Models & Mechanisms
|
December 3, 2008
Aberrant RNA splicing and its functional consequences in cancer cells
James D Fackenthal, Lucy A Godley
Nature Reviews. Cancer
|
November 24, 2007
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
James D Fackenthal, Olufunmilayo I Olopade
Annals of Epidemiology
|
December 3, 2014
Changes in the pattern of breast cancer burden among African American women: evidence based on 29 states and District of Columbia during 1998 to 2010
Dominique Sighoko, James D Fackenthal, Pierre Hainaut
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2012
Hidden dangers: a cryptic exon disrupts BRCA2 mRNA
James D Fackenthal, Younghee Lee, Olufunmilayo I Olopade
Breast Cancer Research and Treatment
|
July 3, 2010
Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population
Jing Zhang, James D Fackenthal, Dezheng Huo, et al.
American Journal of Human Genetics
|
July 30, 2002
BRCA2 T2722R is a deleterious allele that causes exon skipping
James D Fackenthal, Luca Cartegni, Adrian R Krainer, et al.
Cancer
|
March 19, 2016
Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect
Rodrigo Santa Cruz Guindalini, Andrew Song, James D Fackenthal, et al.
Cancer
|
December 20, 2002
Breast cancer genetics in African Americans
Olufunmilayo I Olopade, James D Fackenthal, Georgia Dunston, et al.
Familial Cancer
|
August 6, 2008
Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry
Bifeng Zhang, James D Fackenthal, Qun Niu, et al.
Page
of 2